Repligen Appeals Ruling in Dispute with Bristol-Myers

Law360, New York (October 10, 2003, 12:00 AM EDT) -- Biotech company Repligen Corporation has appealed the ruling in its lawsuit against Bristol-Myers Squibb, the company said in a statement.

In September, the United States District Court for the Eastern District of Michigan ruled that there was insufficient evidence for a university scientist to be named as an inventor on these patents. The lawsuit was filed by Repligen and the University of Michigan.

The dispute concerns key patents regarding a compound now in testing for rheumatoid arthritis. It dates back to a now-defunct research collaboration between...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.